Hyatt Regency
5 Embarcadero Center
San Francisco, CA
Wilson Sonsini proudly sponsors the Life Sciences Patent Network (LSPN) Fall 2024 meeting.
On Tuesday, October 15th at 11:50 am, partner Wendy Devine will moderate the panel session, "Aligning innovation, regulation, and IP protection" with Jesse Fecker, VP, Head of IP, at Theravance Bio; Christina Susanto, Director of IP, at Sutro Biopharma, and Lawrence Kong, Executive Director, Legal, and Intellectual Property, at Addition Therapeutics.
On Wednesday, October 16th at 11:20 am, partner Maya Skubatch will lead a roundtable discussion entitled "Avoiding pitfalls and best strategies for patenting antibodies and biologics."
At LSPN Fall 2024, 150+ delegates will have a chance to hear from leading experts as they unpack the latest IP trends and best practices in the life sciences industry.
Norilyn Ingram
ningram@wsgr.com
Wendy is the firm's patent litigation practice leader and she represents clients in patent litigation and IP-related matters.
Maya Skubatch was a partner in the Palo Alto office of Wilson Sonsini Goodrich & Rosati and a former member of the firm’s board of directors. Maya focused on strategic patent counseling for both private and public life science companies. She worked closely with licensing, litigation, corporate, and regulatory counsel to provide integrated IP strategies and often assists clients with intellectual property matters pertaining to financings, M&A, and partnership deals. Maya also worked with investors on IP diligence matters.